CrossFuel Ripped TFX
Natural health product licensed in Canada
- Licence holder
- Wellnx Life Sciences Inc./ Altrex Nutrition/ Wellnx Distribution Inc.
- NPN or DIN-HM
- 80080465
- Status
- Active licence
- Licence date
- 5 October 2017
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 7,9-Dihydro-1,3,7,9-tétraméthyl-1H-purine-2,6,8(3H)-trione Source : Théacrine | 50 mg | Not calculated |
| Ginkgo biloba Source : Feuille Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 666.5 mg Potency : 24 % Flavonoid glycosides | 13.33 mg | Not calculated |
| Ginkgo biloba Source : Feuille Potency : 6 % Terpene lactones | Not specified | Not calculated |
| 4-hydroxy-alpha-[(méthylamino)méthyl]benzèneméthanol Source : Citrus aurantium - Fruit peel | 20 mg | Not calculated |
| 1,3,7-triméthylxanthine Source : Caféine | 160 mg | Not calculated |
| Extrait de fève de café vert Source : Coffea canephora - Graine Extract : Matériel brut sec Extraction ratio : 2:1 Dry plant equivalent : 400 mg Potency : 45 % Chlorogenic acids | 200 mg | Not calculated |
| Olea europaea Source : Feuille Potency : 20 % Oleuropein | 50 mg | Not calculated |
Non-medicinal ingredients
Phosphate de dicalcium dihydraté, Hydroxypropylméthylcellulose, Cellulose microcristalline, Poly(éthylène glycol), Hypromellose, Stéarate de magnésium, Acide stéarique, Dioxyde de silicium, Croscarmellose de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 2 Tous les jours |
Uses authorised in Canada
Could be a complement to a healthy lifestyle that incorporates a calorie-reduced diet and regular physical activity for individuals involved in a weight management program. Provides antioxidants. Helps (temporarily) to promote alertness and wakefulness, and to enhance cognitive performance. Helps (temporarily) to relieve fatigue, to promote endurance, and to enhance motor performance.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are taking health products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils, vitamin E) as this may increase the risk of spontaneous bleeding. If you are pregnant, do not use this product.
- Précautions et mises en garde
Consult a health care practitioner if you are of childbearing age or breastfeeding. Consult a health care practitioner prior to use if you are taking medications for diabetes, high blood pressure, or seizures. Consult a health care practitioner prior to use if you are taking lithium. Consult a health care practitioner prior to use if you have high blood pressure, glaucoma, and/or detrusor instability (overactive bladder syndrome). Consumption with natural health products (e.g. bitter orange extract, synephrine, octopamine, ephedra) or other drugs (e.g. ephedrine) which increase blood pressure is not recommended. Consumption caffeine-containing products (e.g. medications, coffee, tea, cola, guarana, mate) is not recommended as it may increase the risk of adverse effect. This product is not intended as a substitute for sleep. If you are taking other diuretics, consult a health care practitioner prior to use. If you have a kidney disorder, consult a health care practitioner prior to use. If you have heart disease, high or low blood pressure, kidney or liver disorder, diabetes or edema (swelling of hands, face and feet) or are taking products containing diuretics, do not use. Consult a health care practitioner prior to use if you are taking prescription medication. Do not consume if you are taking decongestant-containing cold preparations (i.e. phenylephrine or pseudoephedrine), products containing ephedra or ephedrine, or other medications which increase blood pressure. Do not consume if you are taking decongestant-containing cold preparations (i.e. phenylephrine or pseudoephedrine). Ensure to drink enough fluid before, during, and after exercise. Caffeine has been shown to reduce blood flow to the heart muscle during exercise which might lead to cardiovascular complications such as chest pain, and irregular heartbeat even in healthy individuals. If those symptoms occur discontinue use and consult a health care practitioner. Diuretic might occur. Stop use and seek medical attention immediately if you experience dizziness, confusion, muscle weakness or pain, abnormal heart beat and/or difficulty breathing. Consult a health care practitioner prior to use if you have prostate disorders.
- Effets indésirables connus
Hypersensitivity/allergy is known to occur, in which case, discontinue use. Allergic reactions can occur in people allergic to plants of the Oleaceae family.
Source
Official Health Canada record, licence 80080465
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.